SMG, US8101861065

UBS upgrades Scotts Miracle-Gro stock to Buy with USD 70 target

Published on 10/15/2026 at 13:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS cuts its target to USD 70 from USD 78 on October 15, 2026. Scotts Miracle-Gro stock costs EUR 45.15 on October 15, 2026, while UBS set USD 70.

Analyst action and quarterly figures

  • UBS upgraded the rating and set a USD 70 target from USD 78 on October 15, 2026.
  • Fiscal third-quarter revenue reached USD 1.17 billion and rose 1 percent year over year.
  • Scotts Miracle-Gro stock was trading at EUR 45.15 at 1:39 p.m. CEST at Lang & Schwarz on October 15, 2026.
SMG, US8101861065, Illustration mit AI erstellt.
SMG, US8101861065, Illustration mit AI erstellt.

The Scotts Miracle-Gro Company (US8101861065) was trading at EUR 45.15 at Lang & Schwarz on October 15, 2026 at 1:39 p.m. CEST. Investing.com reported on October 15, 2026 that UBS upgraded the stock to Buy from Neutral while cutting its price target to USD 70 from USD 78. The change puts valuation at the center of the current stock debate.

Three dates shaped the stock

The recent sequence began on September 15, 2026, when Scotts Miracle-Gro reaffirmed fiscal 2026 guidance and cited a free cash flow target of USD 275 million in its company release. On September 29, 2026, Investing.com reported that Stifel lowered its target to USD 75 from USD 76 while maintaining a Buy rating. UBS supplied the latest event on October 15, 2026 with its Buy upgrade and USD 70 target.

What does the USD 70 target change?

The rating change is constructive, but the lower target shows that UBS is separating its view on valuation from its earlier price objective. The same Investing.com report said fiscal third-quarter 2026 adjusted earnings per share reached USD 2.82 versus USD 2.48 expected, while revenue was USD 1.17 billion, up 1 percent from the prior year. Those figures give the Buy call an operating basis, although the report also highlighted inflation and uneven consumer conditions as risks.

Next reporting date is November 4

The company says its fiscal 2026 results are scheduled for November 4, 2026, following the September 30, 2026 fiscal year-end, according to its investor-relations page. The upcoming release should show whether the USD 4.30 to USD 4.45 adjusted earnings-per-share outlook and USD 275 million free cash flow target remain intact.

Valuation remains the market question

Structured market figures place Scotts Miracle-Gro at a USD 2.9 billion market capitalization as of October 14, 2026, with a USD 47.90 to USD 75.34 52-week range. The latest US quote was USD 49.72 before the October 15, 2026 session, leaving the stock near the lower end of that range while the euro quotation provides the German investor perspective.

Stock trades on analyst news

The Scotts Miracle-Gro Company combines branded lawn and garden products with indoor growing products, and its next results will test the balance between margin improvement and consumer demand.

The further course of trading is shown by the continuously updated real-time quote of Scotts Miracle-Gro stock.

Scotts Miracle-Gro stock facts

  • Company: The Scotts Miracle-Gro Company
  • ISIN: US8101861065
  • Ticker: SMG
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 15, 2026, 1:39 p.m. CEST): EUR 45.15
  • Market capitalization: USD 2.9 billion (as of October 14, 2026)
  • 52-week range: USD 47.90-USD 75.34 (as of October 14, 2026)
  • Sector / Industry: Basic Materials / Agricultural Inputs
  • Next earnings date: November 4, 2026

Market context: Market report S&P 500.

More news and analyses on Scotts Miracle-Gro stock

Disclaimer...

en | US8101861065 | SMG | boerse | 70329717 | bgmi